1. Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway
    Simin Liang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  2. The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
    Reid P. Bissonnette et al, 2021, BMC Cancer CrossRef
  3. Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer
    Wenfang Bao et al, 2022, Pharmaceutical Research CrossRef
  4. Novel molecular targets in hepatocellular carcinoma
    Ariel Ka-Man Chow et al, 2020, World Journal of Clinical Oncology CrossRef
  5. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway
    Jianan Zhou et al, 2018, Investigational New Drugs CrossRef

  6. The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer


    Wanjun Zhang et al, 2020, OncoTargets and Therapy CrossRef